Identification of genes differentially expressed in SH-SY5Y neuroblastoma cells exposed to the prion peptide 106-126

Eur J Neurosci. 2007 Jul;26(1):51-9. doi: 10.1111/j.1460-9568.2007.05646.x. Epub 2007 Jun 26.

Abstract

Prion diseases are a group of neurodegenerative disorders characterized by astrocytosis and progressive neuronal degeneration. As a causative agent, prions have been intensely investigated in different experimental models. However, the mechanisms and pathways involved in the prion-induced neurological dysfunction are poorly understood. In this work we have investigated the influence of prion infection on the gene expression profile in a human neuroblastoma cell line. Using a DNA microarray and quantitative reverse transcriptase-polymerase chain reaction methods, we have analysed in SH-SY5Y cells the effects of a synthetic peptide corresponding to the 106-126 neurotoxic region of the cellular human prion protein. Our results show that addition of this peptide to the neuronal culture specifically changes the expression of a relative high number of genes, and causes a progressive neuronal death even in the absence of microglia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Death / physiology
  • Cell Line, Tumor
  • Down-Regulation / genetics
  • Down-Regulation / physiology
  • Gene Expression / physiology*
  • Humans
  • Microscopy, Fluorescence
  • Neuroblastoma / genetics*
  • Neuroblastoma / metabolism*
  • Neuroglia / drug effects
  • Neuroglia / metabolism
  • Oligonucleotide Array Sequence Analysis
  • Peptide Fragments / pharmacology*
  • Prions / genetics
  • Prions / pharmacology*
  • RNA / biosynthesis
  • RNA / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tetrazolium Salts
  • Thiazoles
  • Transcription, Genetic

Substances

  • Peptide Fragments
  • Prions
  • Tetrazolium Salts
  • Thiazoles
  • prion protein (106-126)
  • RNA
  • thiazolyl blue